Search Results - "Scholey, James W."

Refine Results
  1. 1

    Kidney ACE2 expression: Implications for chronic kidney disease by Maksimowski, Nicholas, Williams, Vanessa R, Scholey, James W

    Published in PloS one (30-10-2020)
    “…Angiotensin-converting enzyme 2 (ACE2) has been implicated in the pathogenesis of chronic kidney disease (CKD) and is a membrane receptor for severe acute…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Chronology of mitochondrial and cellular events during skeletal muscle ischemia-reperfusion by Paradis, Stéphanie, Charles, Anne-Laure, Meyer, Alain, Lejay, Anne, Scholey, James W, Chakfé, Nabil, Zoll, Joffrey, Geny, Bernard

    “…Peripheral artery disease (PAD) is a common circulatory disorder of the lower limb arteries that reduces functional capacity and quality of life of patients…”
    Get more information
    Journal Article
  4. 4

    Remission of Proteinuria Improves Prognosis in IgA Nephropathy by REICH, Heather N, TROYANOV, Stéphan, SCHOLEY, James W, CATTRAN, Daniel C

    “…Proteinuria has been shown to be an adverse prognostic factor in IgA nephropathy. The benefit of achieving a partial remission of proteinuria, however, has not…”
    Get full text
    Journal Article
  5. 5

    Prevention of Angiotensin II–Mediated Renal Oxidative Stress, Inflammation, and Fibrosis by Angiotensin-Converting Enzyme 2 by Zhong, JiuChang, Guo, Danny, Chen, Christopher B, Wang, Wang, Schuster, Manfred, Loibner, Hans, Penninger, Josef M, Scholey, James W, Kassiri, Zamaneh, Oudit, Gavin Y

    Published in Hypertension (Dallas, Tex. 1979) (01-02-2011)
    “…Angiotensin-converting enzyme 2 (ACE2) is a monocarboxypeptidase capable of metabolizing angiotensin (Ang) II into Ang 1 to 7. We hypothesized that ACE2 is a…”
    Get full text
    Journal Article
  6. 6

    Sex and kidney ACE2 expression in primary focal segmental glomerulosclerosis: A NEPTUNE study by Maksimowski, Nicholas A, Scholey, James W, Williams, Vanessa R

    Published in PloS one (07-06-2021)
    “…Background Angiotensin-converting enzyme 2 (ACE2) has been implicated in the pathogenesis of experimental kidney disease. ACE2 is on the X chromosome, and in…”
    Get full text
    Journal Article
  7. 7

    Angiotensin-[1–7] attenuates kidney injury in experimental Alport syndrome by Choi, Hong Sang, Kim, In Jin, Kim, Chang Seong, Ma, Seong Kwon, Scholey, James W., Kim, Soo Wan, Bae, Eun Hui

    Published in Scientific reports (06-03-2020)
    “…Angiotensin-[1–7] (Ang-[1–7]) antagonize the actions of the renin-angiotensin-system via the Mas receptor and thereby exert renoprotective effects. Murine…”
    Get full text
    Journal Article
  8. 8

    Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy by OUDIT, Gavin Y, LIU, George C, HERZENBERG, Andrew M, KASSIRI, Zamaneh, SCHOLEY, James W, JIUCHANG ZHONG, BASU, Ratnadeep, CHOW, Fung L, ZHOU, Joyce, LOIBNER, Hans, JANZEK, Evelyne, SCHUSTER, Manfred, PENNINGER, Josef M

    Published in Diabetes (New York, N.Y.) (01-02-2010)
    “…Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy Gavin Y. Oudit 1 , 2 , George C. Liu 3 , JiuChang Zhong 1 , 2 , Ratnadeep Basu 1 , 2 ,…”
    Get full text
    Journal Article
  9. 9

    Adiponectin attenuates angiotensin II-induced oxidative stress in renal tubular cells through AMPK and cAMP-Epac signal transduction pathways by Fang, Fei, Liu, George C, Kim, Crystal, Yassa, Rana, Zhou, Joyce, Scholey, James W

    “…Obesity is a risk factor for chronic kidney disease (CKD) progression. Circulating levels of adiponectin, an adipokine, decrease with obesity and play a…”
    Get more information
    Journal Article
  10. 10

    Follistatin-Like-1 (FSTL1) Is a Fibroblast-Derived Growth Factor That Contributes to Progression of Chronic Kidney Disease by Maksimowski, Nicholas A, Song, Xuewen, Bae, Eun Hui, Reich, Heather, John, Rohan, Pei, York, Scholey, James W, Nephrotic Syndrome Study Network Neptune

    “…Our understanding of the mechanisms responsible for the progression of chronic kidney disease (CKD) is incomplete. Microarray analysis of kidneys at 4 and 7…”
    Get full text
    Journal Article
  11. 11

    Inhibition of BRD4 Reduces Neutrophil Activation and Adhesion to the Vascular Endothelium Following Ischemia Reperfusion Injury by Reid, Shelby, Fine, Noah, Bhosle, Vikrant K, Zhou, Joyce, John, Rohan, Glogauer, Michael, Robinson, Lisa A, Scholey, James W

    “…Renal ischemia reperfusion injury (IRI) is associated with inflammation, including neutrophil infiltration that exacerbates the initial ischemic insult. The…”
    Get full text
    Journal Article
  12. 12

    Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction by Kassiri, Zamaneh, Zhong, Jiuchang, Guo, Danny, Basu, Ratnadeep, Wang, Xiuhua, Liu, Peter P, Scholey, James W, Penninger, Josef M, Oudit, Gavin Y

    Published in Circulation. Heart failure (01-09-2009)
    “…Angiotensin-converting enzyme 2 (ACE2) is a monocarboxypeptidase that metabolizes Ang II into Ang 1-7, thereby functioning as a negative regulator of the…”
    Get full text
    Journal Article
  13. 13

    Olmesartan Attenuates Kidney Fibrosis in a Murine Model of Alport Syndrome by Suppressing Tubular Expression of TGFβ by Suh, Sang Heon, Choi, Hong Sang, Kim, Chang Seong, Kim, In Jin, Ma, Seong Kwon, Scholey, James W, Kim, Soo Wan, Bae, Eun Hui

    “…Despite the wide use of angiotensin II receptor blockers in the treatment of Alport syndrome (AS), the mechanism as to how angiotensin II receptor blockers…”
    Get full text
    Journal Article
  14. 14

    Urinary proteomics links keratan sulfate degradation and lysosomal enzymes to early type 1 diabetes by Van, Julie A D, Clotet-Freixas, Sergi, Hauschild, Anne-Christin, Batruch, Ihor, Jurisica, Igor, Elia, Yesmino, Mahmud, Farid H, Sochett, Etienne, Diamandis, Eleftherios P, Scholey, James W, Konvalinka, Ana

    Published in PloS one (26-05-2020)
    “…Diabetes is the leading cause of end-stage renal disease worldwide. Our understanding of the early kidney response to chronic hyperglycemia remains incomplete…”
    Get full text
    Journal Article
  15. 15

    Angiotensin-(1-7)-induced activation of ERK1/2 is cAMP/protein kinase A-dependent in glomerular mesangial cells by Liu, George C, Oudit, Gavin Y, Fang, Fei, Zhou, Joyce, Scholey, James W

    “…The renin-angiotensin system (RAS) plays an important role in renal physiology and kidney injury. Although the cellular effects of the RAS activation are…”
    Get more information
    Journal Article
  16. 16

    The molecular phenotype of endocapillary proliferation: novel therapeutic targets for IgA nephropathy by Hodgin, Jeffrey B, Berthier, Celine C, John, Rohan, Grone, Elisabeth, Porubsky, Stefan, Gröne, Hermann-Josef, Herzenberg, Andrew M, Scholey, James W, Hladunewich, Michelle, Cattran, Daniel C, Kretzler, Matthias, Reich, Heather N

    Published in PloS one (18-08-2014)
    “…IgA nephropathy (IgAN) is a clinically and pathologically heterogeneous disease. Endocapillary proliferation is associated with higher risk of progressive…”
    Get full text
    Journal Article
  17. 17

    A molecular signature of proteinuria in glomerulonephritis by Reich, Heather N, Tritchler, David, Cattran, Daniel C, Herzenberg, Andrew M, Eichinger, Felix, Boucherot, Anissa, Henger, Anna, Berthier, Celine C, Nair, Viji, Cohen, Clemens D, Scholey, James W, Kretzler, Matthias

    Published in PloS one (18-10-2010)
    “…Proteinuria is the most important predictor of outcome in glomerulonephritis and experimental data suggest that the tubular cell response to proteinuria is an…”
    Get full text
    Journal Article
  18. 18

    Characterization of the Intrarenal Renin-Angiotensin System in Experimental Alport Syndrome by Bae, Eun Hui, Konvalinka, Ana, Fang, Fei, Zhou, Xiaohua, Williams, Vanessa, Maksimowski, Nicholas, Song, Xuewen, Zhang, Shao-Ling, John, Rohan, Oudit, Gavin Y, Pei, York, Scholey, James W

    Published in The American journal of pathology (01-05-2015)
    “…Blockade of the renin-angiotensin system attenuates the progression of experimental and clinical Alport syndrome (AS); however, the underlying mechanism(s)…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Recent Approaches to Targeting Canonical NF κ B Signaling in the Early Inflammatory Response to Renal IRI by Reid, Shelby, Scholey, James W

    “…Ischemia reperfusion injury (IRI) is the most common cause of in-hospital AKI and is associated with increased morbidity and mortality. IRI is associated with…”
    Get full text
    Journal Article